Search Results - "Carriero, Maria Vincenza"
-
1
The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling
Published in Current pharmaceutical design (01-06-2011)“…Urokinase (uPA) was originally identified in human urine for its ability to catalyse the transformation of plasminogen into its active form, plasmin which…”
Get more information
Journal Article -
2
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Published in Frontiers in oncology (15-11-2019)“…Tumor Associated Neutrophils (TANs) are engaged into the tumor microenvironment by cytokines and chemokines, can be distinguished according to their activation…”
Get full text
Journal Article -
3
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis
Published in Frontiers in immunology (16-09-2020)“…Neutrophil Extracellular Traps (NETs) are net-like structures composed of DNA-histone complexes and proteins released by activated neutrophils. In addition to…”
Get full text
Journal Article -
4
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization
Published in Blood (01-03-2005)“…We investigated the involvement of the urokinase-type plasminogen-activator receptor (uPAR) in granulocyte–colony-stimulating factor (G-CSF)–induced…”
Get full text
Journal Article -
5
Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors
Published in Current drug targets (01-11-2011)“…Urokinase (uPA) is a 411 residues serine protease originally identified for its ability to activate plasminogen and generate plasmin, a broad-spectrum matrix-…”
Get more information
Journal Article -
6
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
Published in Frontiers in oncology (21-02-2019)“…Disseminating Cancer Stem Cells (CSCs) initiate growth in specific niches of the host tissues, the cellular and molecular components of which sustain signaling…”
Get full text
Journal Article -
7
Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
Published in International journal of molecular sciences (23-03-2023)“…Gastrointestinal stromal tumors (GISTs) are the most common malignant mesenchymal neoplasms of the gastrointestinal tract. The gold standard for the diagnosis…”
Get full text
Journal Article -
8
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
Published in International journal of molecular sciences (26-06-2020)“…Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall…”
Get full text
Journal Article -
9
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins
Published in International journal of molecular sciences (09-08-2018)“…Neutrophil extracellular traps (NETs), in addition to their function as a host defense mechanism, play a relevant role in thrombus formation and metastatic…”
Get full text
Journal Article -
10
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells
Published in PloS one (06-02-2017)“…Neutrophil extracellular traps (NETs), originally recognized as a host defense mechanism, were reported to promote thrombosis and metastatic dissemination of…”
Get full text
Journal Article -
11
Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development
Published in Frontiers in endocrinology (Lausanne) (30-04-2018)“…was first described as a metastasis suppressor gene in malignant melanoma. encodes a 145 amino-acid residue peptide that is further processed, producing the 54…”
Get full text
Journal Article -
12
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
Published in Journal of experimental & clinical cancer research (27-11-2023)“…Abstract Background BRAF-mutant melanoma patients benefit from the combinatorial treatments with BRAF and MEK inhibitors. However, acquired drug resistance…”
Get full text
Journal Article -
13
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
Published in Frontiers in oncology (15-04-2020)“…This work describes the set-up of a shared platform among the laboratories of the Alleanza Contro il Cancro (ACC) Italian Research Network for the…”
Get full text
Journal Article -
14
A Macroscopic Mathematical Model for Cell Migration Assays Using a Real-Time Cell Analysis
Published in PloS one (28-09-2016)“…Experiments of cell migration and chemotaxis assays have been classically performed in the so-called Boyden Chambers. A recent technology, xCELLigence Real…”
Get full text
Journal Article -
15
Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
Published in Scientific reports (02-05-2017)“…The development of metastases is a multistep process that requires the activation of physiological and biochemical processes that govern migration, invasion…”
Get full text
Journal Article -
16
Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes
Published in PloS one (04-05-2015)“…The receptor for the urokinase-type plasminogen activator (uPAR) is a widely recognized master regulator of cell migration and uPAR88-92 is the minimal…”
Get full text
Journal Article -
17
Emerging Treatments Targeting the Tumor Microenvironment for Advanced Chondrosarcoma
Published in Cells (Basel, Switzerland) (01-06-2024)“…Chondrosarcoma (ChS), a malignant cartilage-producing tumor, is the second most frequently diagnosed osseous sarcoma after osteosarcoma. It represents a very…”
Get full text
Journal Article -
18
Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer
Published in Translational oncology (01-03-2021)“…•We have identified 201 altered chromosomal bands and 3300 altered genes in human ovarian cancer samples.•The gene encoding for PDCD10 was selected for further…”
Get full text
Journal Article -
19
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
Published in Journal of experimental & clinical cancer research (08-11-2019)“…The biological behavior of epithelial ovarian cancer (EOC) is unique since EOC cells metastasize early to the peritoneum. Thereby, new anti-target agents…”
Get full text
Journal Article -
20
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
Published in Journal of experimental & clinical cancer research (08-12-2017)“…Accumulating evidence demonstrates that the Urokinase Receptor (uPAR) regulates tumor cell migration through its assembly in composite regulatory units with…”
Get full text
Journal Article